Received: from DB3PEPF00008859.eurprd02.prod.outlook.com (2603:10a6:10:553:cafe::f1) by DU7P194CA0007.outlook.office365.com (2603:10a6:10:553::30) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9769.41 via Frontend Transport; Fri, 10 Apr 2026 08:48:58 +0000 Received: from DU7P194CA0007.EURP194.PROD.OUTLOOK.COM (2603:10a6:10:553::30) by DB9PR02MB8818.eurprd02.prod.outlook.com (2603:10a6:10:3c5::14) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9769.42; Fri, 10 Apr 2026 08:48:58 +0000 Received: from mail1.rit.ee (213.184.53.4) by DB3PEPF00008859.mail.protection.outlook.com (10.167.242.4) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9769.17 via Frontend Transport; Fri, 10 Apr 2026 08:48:57 +0000 Received: from srvexch1.kliinikum.ee (HELO outlook.kliinikum.ee) ([192.168.20.105]) by spamgwp8.kliinikum.ee with ESMTP/TLS/ECDHE-RSA-AES128-GCM-SHA256; 10 Apr 2026 11:48:56 +0300 Received: from srvexch1.kliinikum.ee ([192.168.20.105]) by srvexch1.kliinikum.ee ([192.168.20.105]) with mapi id 15.01.2375.031; Fri, 10 Apr 2026 11:48:56 +0300 Received: from srvexch1.kliinikum.ee (192.168.20.105) by srvexch1.kliinikum.ee (192.168.20.105) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id 15.1.2375.31; Fri, 10 Apr 2026 11:48:56 +0300 Received: from DB9PR02MB8818.eurprd02.prod.outlook.com (2603:10a6:10:3c5::14) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Fri, 10 Apr 2026 08:49:00 +0000 From: =?windows-1257?Q?J=FCrgen_K=FCtner?= To: "Info - SOM" Subject: ATH ravimid Date: Fri, 10 Apr 2026 11:48:56 +0300 Keywords: Mall Message-ID: <6f1a225ca11b4ea0a110a27b19f8f8d0@kliinikum.ee> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_001C_01DCC8E5.80B2CDE0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQGrdvz7EzyG31WdGDlXGwixKAX5zg== Authentication-Results: spf=fail (sender IP is 213.184.53.4) smtp.mailfrom=kliinikum.ee; dkim=pass (signature was verified) header.d=kliinikum.ee;dmarc=pass action=none header.from=kliinikum.ee;compauth=pass reason=100 X-CSE-ConnectionGUID: reomPQDURdS7O8sFogFUaQ== X-CSE-ConnectionGUID: dUgckZ/JTOyyNvSXmvEIBA== X-CSE-MsgGUID: CAZ8Yk/MTUuieTnGzU8A/Q== X-CSE-MsgGUID: irm98B6ZRseOsDyF+0BraA== X-ThreatScanner-Verdict: Negative X-Talos-CUID: =?us-ascii?q?9a23=3AvuzPL2ppXPbQ/zDvKn4M1uPmUcwYfXbe/jDyH2i?= =?us-ascii?q?pGEB3c42QV3Kx0ooxxg=3D=3D?= X-Talos-MUID: 9a23:nYg7JArgMtu+ThoDR1IezxpLBpdZ4OOLNH0QkJg6veaWCHxZfA7I2Q== X-IronPort-AV: E=Sophos;i="6.23,171,1770588000"; d="scan'208,217";a="66663130" X-MS-Exchange-Organization-ExpirationStartTime: 10 Apr 2026 08:48:58.1359 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: e0e5755c-1570-40c5-795b-08de96de0144 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DB3PEPF00008859:EE_|DB9PR02MB8818:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: DB3PEPF00008859.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: e0e5755c-1570-40c5-795b-08de96de0144 X-MS-Exchange-AtpMessageProperties: SA|SL X-DisclaimerOO: 1 X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704162311799003|82310400026|16102099003|19002099003|56012099003|8096899003|55112099003; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704162311799003)(82310400026)(16102099003)(19002099003)(56012099003)(8096899003)(55112099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 10 Apr 2026 08:48:57.9547 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: e0e5755c-1570-40c5-795b-08de96de0144 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB3PEPF00008859.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9PR02MB8818 X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.8094096 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9769.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4717077)(4999163)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?u3BG4EpDGyLC///KVSKKcGVguj4gxrv/bL1du1PPjVsmYDBGLTxna8KKMEbT?= =?us-ascii?Q?Ar/Jes4gx/kmpyBHJRe4ED4Jf2j1/frZfc1UAI+3LXnsLcUtujdTqCwgzkzZ?= =?us-ascii?Q?bae5GLiJ83lIn47lv+Ez5JnCIJk0rkLenB99m57YSVjribvUb9N+JUgICz3O?= =?us-ascii?Q?/hsh+OjNp2lbbotiKty3hpfsW06Sl9hUlJo7aQCAU9/1l90aaT6MSUALhUOj?= =?us-ascii?Q?zEgBZPQ1K0sqtB8B5x1qSq1tks9flHrmn/5k/kU2e+SkUKQK4cuFnxB7gIwr?= =?us-ascii?Q?OZtl0sSjOs0Hhm78e9uIQJ3gVHLf5Ev+mtFp982f9v6B4+jsWAKNWW9HR+32?= =?us-ascii?Q?oRMVyKPDxNRDr45IEVTvPeeYBuZX4B7u1QUmzId6UXO1zlrJRpwcp7dSJgaB?= =?us-ascii?Q?ci/FE3C4m8ntCWFtKD1KBajEyMDs8rMMCQUjniyQHD7+mGaBxNV03fUjtQ+4?= =?us-ascii?Q?TT/JKnaCwCdr/7f01uTfxxA7EX85nghXm7whmGL7dp8bscMDVLnp7YnEOBX8?= =?us-ascii?Q?idlgml/EHbyMIdIn8oXSa2UGx41dWxSWiTGvpQtuDm/cUVCVOpYd7WPYzASz?= =?us-ascii?Q?KkFrM5KGkYpqFNPT2udmg2ql4BtJzHfha35S3CDBOHRnnMsqu2jV7CjvF/qj?= =?us-ascii?Q?SApt3ZteSrZpVhyLRVZVcxHWDGkzpwr9RrGJHdOPP7LhJC9cW5tJVBiQ9sxq?= =?us-ascii?Q?4M8FFDB5HH1PHKCg0Fpr3o21sxo90euvxC/cKR7hzA4CJMNtWq4 zID5aeASY?= =?us-ascii?Q?q7bu1drW8qIC5m4zXgjUcKclP+0kXWqhpgbmuLQmHZYfl9v5yxRjPmkY8jbO?= =?us-ascii?Q?300CIVr8YF4HaL0aqIyQ9KdFw2cCJ+2TMOhp5zERd1oFOWfim+L2xGgoEp+E?= =?us-ascii?Q?rxbgAydutvDK0L1J5elke1K2B3lqivcXl0je1jZP0S3jG+0JHqTsFsfK6pVH?= =?us-ascii?Q?6It/Glo/Ug/CrG1vZwRvSwSag/zZtpnAcZt7gng0+NEVu0AbfXzoqtdnxR81?= =?us-ascii?Q?WVF9ku3gMGR+SUSuvm/P3/uHMIYVUB2yDoc2t2gt5IyR3vJ+FvXEw3GuhKOd?= =?us-ascii?Q?ij54cOfKEYs6xz1KVD/+Utv6gIK+q/f97lhaDtXL4iE+vMRjuYenUzr5zzLH?= =?us-ascii?Q?3gUu15/6z3FQsCKgMn94lvVJK0EL+e+F5TIwD+SyzEWwsmTFlPqWDXeXikoK?= =?us-ascii?Q?8FQtpn8htdNZBVlRyp2bgaEFM0HaYMhTMDiNJDU5W8SDzf69g8LtIW+XjYV2?= =?us-ascii?Q?GM8DOUI7V6Ngg/kqfi7aumEE1GTXQCfGwTRq9SztweK+WScf4ClAWSnH1zZL?= =?us-ascii?Q?YWh2bFl+Wa2gmymrl1t9cRFnkF8YG5ercrkkh4E15JjElPbqeZJsKHmLfTbY?= =?us-ascii?Q?k+wDu2kEZQuuI6LTCtokMHcGaEanDs8bbUYvJMg1YekEg0I/H5sYLsRzgGWe?= =?us-ascii?Q?B6QK9mVUJC3MKopdEhxZijIzWsRWTvJCgqGPy8n3r6s/b+W8aZ5/d4Vz85i+?= =?us-ascii?Q?H2yBpBhtCdc7zfRwjnF32QQyxGCwvb/OKWweJ arHfbihHKDoSSFvclvz3THk?= =?us-ascii?Q?W+BUSQe/WeokukmOXE8+95vVg6YkuITb4At3PAGavAi5CSgZmiWeZ0La/Afw?= =?us-ascii?Q?E3c735fe9ss34xopmf4ZMcS6kqUB2urfEMpZcPzNINlF/JGfYLIrvZG9DKO+?= =?us-ascii?Q?lRH6sILJJeSvyJXpoXgpb2qv9MSoX7gUo7XXCmow0PvGjZMR/UTsVRuWXbjo?= =?us-ascii?Q?uVJ+5jxlPXp44p6HNY9L4dH3LrCLmlT1OkXUkjtqxbVt8EeIFATune8821z3?= =?us-ascii?Q?YDhAt/bHf//WaFN/NpJU83AA8o9sCDaDCBddzBt/mMoZ6Ef6nxS+HYvveFXd?= =?us-ascii?Q?YSKH5w0YxYs/dFGN47cPeF6lOcGAAprj7CsMJX/ZhVV38PgRwVRPIuLxQFcm?= =?us-ascii?Q?F4ylg1tAsB9DSWcSlqb1H4FDySWu/lwk3PvfWaQkOaetiFJxPQHtBvTg4SJf?= =?us-ascii?Q?a/lGUBLX0hXQuVaQ4U7ByEUc/zwhMoVGB+mqIj7NrUF7jmmL2nwFNddvl4FA?= =?us-ascii?Q?9aG6+WAVRh2aKS6xv8G1gSIW5tOCnjTeRZue1HGCjFnOOrVkL/zi/FXGi+KB?= =?us-ascii?Q?d2/OmdHfKqhCi8KzCeszBQO6xVxeFAYcucxhtFsCkd0FUsxmcV8NUhXcrQVP?= =?us-ascii?Q?74J73lJjz5mpdbdE8uENGA0GwuQPrPfCdZ91PnThqW1rcF1an777Xin3JaZg?= =?us-ascii?Q?DK5IB63z9XbzMlttSbzfH+1h08iHZUgp6f3HYyb3gqcVqDi/lnxWumoiaatE?= =?us-ascii?Q?hu19Ka5RG9FMUeBCYddNu1E fqLM737UsbJhtqgSnIl8/Mz4f2/UJTcKTflzi?= =?us-ascii?Q?uBu7qBBca4eL1h4j4l0I0hzXZv3hQOOuA1dIxwRKLbh8XL9DxQqUjehVNiJ1?= =?us-ascii?Q?yaDX+dOhZnECTxqOvcwjjM0xWzMumNQPASO8fU9IH3366pi2DZh6bKJWYqU7?= =?us-ascii?Q?hGa9Okm8bmqDvrz7Q8V5uQK76qsWq9pr0j0H9gHfJLlS0gPoOuuQfhgpiOX1?= =?us-ascii?Q?7i+mpME7OHpmfG2FeZ7dvIOA5PJybqJPxocmVc9N+YH2u/Ap+wa6bw3j2Uo3?= =?us-ascii?Q?E5jFAGy45ROLZfn+JwF0k2X5s9PsH6PyE1jpnX1dRsiiMqH1TDLEd3KFYr0d?= =?us-ascii?Q?P4TxSGj0MpkKGV5sevIeNI+A52/vvcFxtCV7Cs1lovzrRYaWxzu5jXOe2w4E?= =?us-ascii?Q?8j7hqdneH/q9UVHnrAQ4My+6V0zQ3WvRQfbFn1pA7UYLXDXQDC8opymFbEhP?= =?us-ascii?Q?4LumAkH4yM/X680jSdUmElhjD0cFs3E8bKbbamv/u0rJT6iw/y1rXqMEdA+K?= =?us-ascii?Q?XksZO3vtc7zz66YnjTB055VRNVL2TIcNgpMqnkcPVGwEXFpS13KfrpEVR1MZ?= =?us-ascii?Q?ij0imXABC0Z+GOndrRLf+0oT3teKNEXsaOcQmQ80F9KXP7EDLY19+5tDbWYw?= =?us-ascii?Q?Z/ESCWjXS+n0k/GwGdCXtEdUUzJIMIg+wwcloJ/OX44B1qbEFGIydBzs/lQE?= =?us-ascii?Q?7qCgFaKizVqCAMMDOXTAdwG3R8n4fU3bMpp9tmsYGlkr82NEz60syUDFZgCz?= =?us-ascii?Q?tpumnP2Vd iNXz0lL7Bk9eWkgZ1Aytcd+LKaqvNfG6zpf30a0ppldrdg=3D?= Content-Language: et x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.242.4 received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@spamgwp8.kliinikum.ee) identity=helo; client-ip=185.50.98.202; receiver=mail1.rit.ee; envelope-from="Jurgen.Kutner@kliinikum.ee"; x-sender="postmaster@spamgwp8.kliinikum.ee"; x-conformance=spf_only dkim-signature: v=1; a=rsa-sha256; c=simple/simple; d=kliinikum.ee; s=securemail; t=1775810936; h=from:to:subject:date:message-id:mime-version; bh=fuHQaDuJnNeRB8YsnxXgeBBdxccZGLiTaECWo9lfldw=; b=vN76dYbfdi7c3RYaJYquVGZtmxJMhpNr3qyzAaeU7ZPh6KSfehYZbNnf zNySX8F2Yr2SMJjrGCi2Oe4kLmWM849kkZg5JmrcIjvz85Bef32K71pum 3pYqbWJHXB2l3kBBltFR37HFp1dU1UzR7SJn+E7/0CihDiCJn6DwGC+bl o=; X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000C9400008BF0662DEF349A449F760B49C0DF2398 X-IPAS-Result: =?us-ascii?q?A0G0CACcuNhpe8piMrlaglmBPYEEgQdeMQMEC0kdAQEBl?= =?us-ascii?q?kCSBoUshleBfw8BAQEBAQELAU4BAgQBAQMBA5ItAh4HATUIDgECAQIBAQEBA?= =?us-ascii?q?QMCAwEBAQEBAQEBAQEBCwEBAQQBAQECAQECBAMBAQEBAhABAUJJhk8BDIJbO?= =?us-ascii?q?4IWLIE+EwEBOBEBBQdzJgEEG4J7gh0FAk8HtlCBAYIMAQEGBAMCAoJd2ykJg?= =?us-ascii?q?U2FBYNSASqBNQGBAoNMD4cCkASCJnoUHY9iLIEYIgMmMywBDxE1ExcLBwUmg?= =?us-ascii?q?UADKi8tbjIdgSM+FwgsWBsHBYFLh16BE4NsgQADCwdmPTcUGwQCAYE1iiRcJ?= =?us-ascii?q?akpjl+VFweEH6FgLheqa4ZAhTKNFCKodAIEAgQFAhiBagE3gVyEJ08DFwIPj?= =?us-ascii?q?i0WhEu+SkYyPwcCBw4ChWoIjDUuAYEcAQE?= X-IronPort-Anti-Spam-Filtered: true X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-MS-Has-Attach: X-MS-TNEF-Correlator: x-originating-ip: [193.40.49.26] acceptlanguage: et-EE, en-US This is a multipart message in MIME format. ------=_NextPart_000_001C_01DCC8E5.80B2CDE0 Content-Type: text/plain; charset="windows-1257" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Kirjutan Eesti Psühhiaatrite Seltsi lastepsühhiaatria sektsioonist seoses hiljuti kehtima hakanud uue ravimimäärusega. Lastepsühhiaatritena sooviks selgust, kui palju võib nüüdsest narkootilise ainega retsepte korraga patsiendile väljastada. Mõnedel patsientidel kogemus, et praegu saab vaid 1 kuu jagu korraga. Kas oskate kommenteerida? Või kelle poole võiks pöörduda? Parimat Jürgen Kütner Lastepsühhiaater Arst-õppejõud Laste ja noorukite vaimse tervise keskus SA TÜK Psühhiaatriakliinik 731 8865 ------=_NextPart_000_001C_01DCC8E5.80B2CDE0 Content-Type: text/html; charset="windows-1257" Content-Transfer-Encoding: quoted-printable

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Tere!

Kirjutan Eesti Ps=FChhiaatrite Seltsi lasteps=FChhiaatria sektsioonist = seoses hiljuti kehtima hakanud uue ravimim=E4=E4rusega.

 

Lasteps=FChhiaatritena sooviks selgust, kui palju = v=F5ib n=FC=FCdsest narkootilise ainega retsepte korraga patsiendile = v=E4ljastada. M=F5nedel patsientidel kogemus, et praegu saab vaid 1 kuu = jagu korraga.

 

Kas oskate kommenteerida? V=F5i kelle poole = v=F5iks p=F6=F6rduda?

 

Parimat

J=FCrgen = K=FCtner

Lasteps=FChhiaater

Arst-=F5ppej=F5ud

=

Laste ja = noorukite vaimse tervise keskus

SA T=DCK = Ps=FChhiaatriakliinik

731 = 8865

 

------=_NextPart_000_001C_01DCC8E5.80B2CDE0--